Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, Chief Executive Officer, and Jerome Wong, Chief Financial Officer, will be participating at the 15th Annual Craig-Hallum Alpha Select Conference taking place in New York on Tuesday, November 19, 2024.
加利福尼亞聖拉斐爾，2024年11月12日，(環球新聞社) -- Ekso Bionics Holdings, Inc. (納斯達克: EKSO) ("公司")，醫療和工業領域外骨骼技術的行業龍頭企業，今日宣佈首席執行官Scott Davis和首席財務官Jerome Wong將參加於2024年11月19日星期二在紐約舉行的第15屆Craig-Hallum Alpha Select Conference。
Management will be participating in one-on-one meetings with institutional investors throughout the conference. For those interested in a meeting, please contact your Craig-Hallum representative.
管理層將在整個會議期間與機構投資者進行一對一會議。有意進行會面的人，請聯繫您的Craig-Hallum代表。
About Ekso Bionics
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol "EKSO." For more information, visit: or follow @EksoBionics on X.
關於Ekso Bionics
Ekso Bionics是領先的外骨骼解決方案開發商，通過支持或增強醫療和工業應用中的力量、耐力和機動性，提高人類潛能。公司成立於2005年，繼續建立其業界領先的專業知識，設計市場上最尖端、最具創新性的可穿戴機器人。Ekso Bionics是已知唯一提供從幫助癱瘓者站起和行走到增強全球工作場地人類能力的外骨骼技術公司。公司總部位於舊金山灣區，股票在納斯達克資本市場上掛牌，代碼爲「EKSO」。有關更多信息，請訪問網站： or follow @EksoBionics on X。
Contact:
David Carey
212-867-1768
investors@eksobionics.com
聯繫方式：
David Carey
212-867-1768
investors@eksobionics.com
譯文內容由第三人軟體翻譯。
